New York: Pregnant mothers who take the COVID-19 vaccine earlier in their third trimester are more likely to pass protective antibodies to their new-born babies, according to a new study.
Published in the American Journal of Obstetrics and Gynaecology, the small study, analysed the blood samples of 27 pregnant women who had received either the Pfizer or Moderna vaccine in their third trimester and the umbilical cord blood of their 28 new-borns (26 singletons, one set of twins).
Following vaccination, women mounted a robust immune response which suggested that the vaccine will protect pregnant women from COVID-19 infections, the researchers from Northwestern Medicine in Illinois, US was quoted as saying by news agency IANS.
Additionally, in most patients, a longer time span (latency) between vaccination and delivery was associated with a more effective transfer of COVID antibodies to the newborn baby.
ALSO READ: COVID-19 Vaccine: Pregnant Women, People Above 60 Years To Get Priority, Says Odisha…
